CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $32,310 | +6.5% | 9,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $30,330 | +117.4% | 9,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $13,950 | +16.2% | 9,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $12,000 | -40.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $20,000 | -31.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $29,000 | -23.7% | 9,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $38,000 | -47.9% | 9,000 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $73,000 | +7.4% | 9,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $68,000 | -12.8% | 9,000 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $78,000 | +8.3% | 9,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $72,000 | 0.0% | 9,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $72,000 | – | 9,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |